Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Phreesia rises 9.4% » 09:47
04/08/21
04/08
09:47
04/08/21
09:47
PHR

Phreesia

$57.36 /

+4.81 (+9.15%)

Phreesia is up 9.4%, or…

Phreesia is up 9.4%, or $4.93 to $57.47.

ShowHide Related Items >><<
PHR Phreesia
$57.36 /

+4.81 (+9.15%)

PHR Phreesia
$57.36 /

+4.81 (+9.15%)

04/01/21 SVB Leerink
Phreesia price target lowered to $75 from $85 at SVB Leerink
04/01/21 Baird
Phreesia initiated with an Outperform at Baird
03/31/21 Piper Sandler
Phreesia price target raised to $58 from $56 at Piper Sandler
03/31/21 KeyBanc
Phreesia price target lowered to $70 from $80 at KeyBanc
PHR Phreesia
$57.36 /

+4.81 (+9.15%)

  • 08
    Apr
  • 21
    Oct
PHR Phreesia
$57.36 /

+4.81 (+9.15%)

PHR Phreesia
$57.36 /

+4.81 (+9.15%)

Syndicate
Phreesia 4.5M share Secondary priced at $50.00 » 06:14
04/08/21
04/08
06:14
04/08/21
06:14
PHR

Phreesia

$52.55 /

-2.58 (-4.68%)

The deal priced priced…

The deal priced priced below the last closing price of $52.54. JPMorgan and William Blair are acting as joint book running managers for the offering.

ShowHide Related Items >><<
PHR Phreesia
$52.55 /

-2.58 (-4.68%)

PHR Phreesia
$52.55 /

-2.58 (-4.68%)

04/01/21 SVB Leerink
Phreesia price target lowered to $75 from $85 at SVB Leerink
04/01/21 Baird
Phreesia initiated with an Outperform at Baird
03/31/21 Piper Sandler
Phreesia price target raised to $58 from $56 at Piper Sandler
03/31/21 KeyBanc
Phreesia price target lowered to $70 from $80 at KeyBanc
PHR Phreesia
$52.55 /

-2.58 (-4.68%)

  • 08
    Apr
  • 21
    Oct
PHR Phreesia
$52.55 /

-2.58 (-4.68%)

PHR Phreesia
$52.55 /

-2.58 (-4.68%)

Tuesday
On The Fly
Fly Intel: After-Hours Movers » 17:55
04/06/21
04/06
17:55
04/06/21
17:55
SGH

Smart Global

$48.71 /

-0.76 (-1.54%)

, NVST

Envista

$40.91 /

-0.82 (-1.97%)

, IDCC

InterDigital

$65.99 /

+0.35 (+0.53%)

, QGEN

Qiagen

$50.00 /

+0.345 (+0.69%)

, MAXN

Maxeon Solar

$28.43 /

-1.76 (-5.83%)

, FGEN

FibroGen

$34.61 /

-0.93 (-2.62%)

, FIXX

Homology Medicines

$9.30 /

-0.34 (-3.53%)

, PHR

Phreesia

$55.13 /

-0.005 (-0.01%)

, IONS

Ionis Pharmaceuticals

$47.25 /

+0.35 (+0.75%)

, LI

Li Auto

$25.52 /

+0.55 (+2.20%)

, OM

Outset Medical

$58.04 /

+1.21 (+2.13%)

Check out this evening's…

ShowHide Related Items >><<
SGH Smart Global
$48.71 /

-0.76 (-1.54%)

QGEN Qiagen
$50.00 /

+0.345 (+0.69%)

PHR Phreesia
$55.13 /

-0.005 (-0.01%)

OM Outset Medical
$58.04 /

+1.21 (+2.13%)

NVST Envista
$40.91 /

-0.82 (-1.97%)

MAXN Maxeon Solar
$28.43 /

-1.76 (-5.83%)

LI Li Auto
$25.52 /

+0.55 (+2.20%)

IONS Ionis Pharmaceuticals
$47.25 /

+0.35 (+0.75%)

IDCC InterDigital
$65.99 /

+0.35 (+0.53%)

FIXX Homology Medicines
$9.30 /

-0.34 (-3.53%)

FGEN FibroGen
$34.61 /

-0.93 (-2.62%)

SGH Smart Global
$48.71 /

-0.76 (-1.54%)

02/10/21 Stifel
Smart Global price target raised to $55 from $48 at Stifel
01/06/21 Needham
Smart Global price target raised to $56 from $39 at Needham
01/06/21 Deutsche Bank
Smart Global price target raised to $48 from $44 at Deutsche Bank
01/04/21 Deutsche Bank
Smart Global price target raised to $44 from $35 at Deutsche Bank
NVST Envista
$40.91 /

-0.82 (-1.97%)

02/11/21 Piper Sandler
Envista price target raised to $41 from $28 at Piper Sandler
01/08/21 Credit Suisse
Envista upgraded to Outperform from Neutral at Credit Suisse
10/30/20 JPMorgan
Envista price target raised to $30 from $28 at JPMorgan
10/30/20 Piper Sandler
Envista price target raised to $28 from $22 at Piper Sandler
IDCC InterDigital
$65.99 /

+0.35 (+0.53%)

03/18/21 B. Riley
B. Riley keeps Buy on InterDigital, still sees renewal opportunity with LG
02/19/21 B. Riley
InterDigital price target raised to $123 from $100 at B. Riley Securities
10/08/20 B. Riley
InterDigital settlement with Lenovo now more likely, says B. Riley Securities
08/27/20 B. Riley
U.K. Supreme Court ruling positive for InterDigital, says B. Riley FBR
QGEN Qiagen
$50.00 /

+0.345 (+0.69%)

02/19/21 Berenberg
Qiagen price target raised to EUR 56 from EUR 52 at Berenberg
02/09/21 William Blair
Quidel, Qiagen merger would not make sense, says William Blair
02/09/21 Wells Fargo
Qiagen shares should be sold on latest merger talk, says Wells Fargo
02/09/21 Citi
Merger with Qiagen would benefit Quidel, says Citi
MAXN Maxeon Solar
$28.43 /

-1.76 (-5.83%)

02/08/21 Roth Capital
Bill could be 'meaningful positive' for solar stocks, says Roth Capital
01/19/21 Roth Capital
Maxeon Solar initiated with a Buy at Roth Capital
01/04/21 Goldman Sachs
Maxeon Solar price target raised to $18 from $15 at Goldman Sachs
11/10/20 Raymond James
Maxeon Solar upgraded to Outperform at Raymond James on Biden election
FGEN FibroGen
$34.61 /

-0.93 (-2.62%)

03/31/21 BofA
BofA upgrades FibroGen to Buy, sees roxadustat approval being 'most likely'
03/31/21 BofA
FibroGen upgraded to Buy from Neutral at BofA
03/02/21
Fly Intel: Top five analyst downgrades
03/02/21 Jefferies
FibroGen downgraded to Hold at Jefferies on increased risk for roxadustat
FIXX Homology Medicines
$9.30 /

-0.34 (-3.53%)

03/01/21 Stifel
Homology Medicines initiated with a Hold at Stifel
03/01/21 Oppenheimer
Homology Medicines loses potential source of upside, says Oppenheimer
12/14/20 H.C. Wainwright
Homology Medicines transferred with Buy, $30 target at H.C. Wainwright
11/08/20 Oppenheimer
Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer
PHR Phreesia
$55.13 /

-0.005 (-0.01%)

04/01/21 SVB Leerink
Phreesia price target lowered to $75 from $85 at SVB Leerink
04/01/21 Baird
Phreesia initiated with an Outperform at Baird
03/31/21 Piper Sandler
Phreesia price target raised to $58 from $56 at Piper Sandler
03/31/21 KeyBanc
Phreesia price target lowered to $70 from $80 at KeyBanc
IONS Ionis Pharmaceuticals
$47.25 /

+0.35 (+0.75%)

03/29/21 Piper Sandler
Ionis' Phase 2 data for PKK-LRx 'impressive' at face value, says Piper Sandler
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
03/23/21 BMO Capital
Ionis Pharmaceuticals price target lowered to $76 from $90 at BMO Capital
LI Li Auto
$25.52 /

+0.55 (+2.20%)

03/11/21
Fly Intel: Top five analyst initiations
03/11/21 Needham
Li Auto initiated with a Buy at Needham
03/11/21 Needham
Li Auto initiated with a Buy at Needham
03/03/21 Wedbush
China growth story worth at least $100/share in bull case to Tesla, says Wedbush
OM Outset Medical
$58.04 /

+1.21 (+2.13%)

12/15/20 Oppenheimer
Oppenheimer starts Outset Medical at Perform, citing competition
12/15/20 Oppenheimer
Outset Medical initiated with a Perform at Oppenheimer
10/12/20
Fly Intel: Top five analyst initiations
10/12/20 Morgan Stanley
Outset Medical initiated with an Equal Weight at Morgan Stanley
SGH Smart Global
$48.71 /

-0.76 (-1.54%)

QGEN Qiagen
$50.00 /

+0.345 (+0.69%)

PHR Phreesia
$55.13 /

-0.005 (-0.01%)

OM Outset Medical
$58.04 /

+1.21 (+2.13%)

NVST Envista
$40.91 /

-0.82 (-1.97%)

MAXN Maxeon Solar
$28.43 /

-1.76 (-5.83%)

LI Li Auto
$25.52 /

+0.55 (+2.20%)

IONS Ionis Pharmaceuticals
$47.25 /

+0.35 (+0.75%)

IDCC InterDigital
$65.99 /

+0.35 (+0.53%)

FIXX Homology Medicines
$9.30 /

-0.34 (-3.53%)

FGEN FibroGen
$34.61 /

-0.93 (-2.62%)

  • 09
    Apr
  • 07
    Apr
  • 08
    Apr
  • 08
    Jan
  • 04
    Dec
  • 03
    Dec
  • 21
    Oct
  • 15
    Sep
  • 30
    Jul
QGEN Qiagen
$50.00 /

+0.345 (+0.69%)

LI Li Auto
$25.52 /

+0.55 (+2.20%)

SGH Smart Global
$48.71 /

-0.76 (-1.54%)

QGEN Qiagen
$50.00 /

+0.345 (+0.69%)

PHR Phreesia
$55.13 /

-0.005 (-0.01%)

OM Outset Medical
$58.04 /

+1.21 (+2.13%)

NVST Envista
$40.91 /

-0.82 (-1.97%)

MAXN Maxeon Solar
$28.43 /

-1.76 (-5.83%)

LI Li Auto
$25.52 /

+0.55 (+2.20%)

IONS Ionis Pharmaceuticals
$47.25 /

+0.35 (+0.75%)

FIXX Homology Medicines
$9.30 /

-0.34 (-3.53%)

FGEN FibroGen
$34.61 /

-0.93 (-2.62%)

SGH Smart Global
$48.71 /

-0.76 (-1.54%)

QGEN Qiagen
$50.00 /

+0.345 (+0.69%)

PHR Phreesia
$55.13 /

-0.005 (-0.01%)

MAXN Maxeon Solar
$28.43 /

-1.76 (-5.83%)

LI Li Auto
$25.52 /

+0.55 (+2.20%)

IONS Ionis Pharmaceuticals
$47.25 /

+0.35 (+0.75%)

FGEN FibroGen
$34.61 /

-0.93 (-2.62%)

Syndicate
Phreesia files to sell 4.5M shares of common stock » 16:10
04/06/21
04/06
16:10
04/06/21
16:10
PHR

Phreesia

$54.86 /

-0.275 (-0.50%)

J.P. Morgan and William…

J.P. Morgan and William Blair are acting as joint book-running managers for the Offering and as representatives of the underwriters. Allen & Company LLC and Piper Sandler are acting as passive book-running managers for the Offering.

ShowHide Related Items >><<
PHR Phreesia
$54.86 /

-0.275 (-0.50%)

PHR Phreesia
$54.86 /

-0.275 (-0.50%)

04/01/21 SVB Leerink
Phreesia price target lowered to $75 from $85 at SVB Leerink
04/01/21 Baird
Phreesia initiated with an Outperform at Baird
03/31/21 Piper Sandler
Phreesia price target raised to $58 from $56 at Piper Sandler
03/31/21 KeyBanc
Phreesia price target lowered to $70 from $80 at KeyBanc
PHR Phreesia
$54.86 /

-0.275 (-0.50%)

  • 21
    Oct
PHR Phreesia
$54.86 /

-0.275 (-0.50%)

PHR Phreesia
$54.86 /

-0.275 (-0.50%)

Conference/Events
Phreesia participates in a conference call with Stephens » 13:25
04/06/21
04/06
13:25
04/06/21
13:25
PHR

Phreesia

$55.56 /

+0.425 (+0.77%)

Conference call with CEO…

Conference call with CEO Indig and CFO Altier to be held on April 6 at 2 pm hosted by Stephens.

ShowHide Related Items >><<
PHR Phreesia
$55.56 /

+0.425 (+0.77%)

PHR Phreesia
$55.56 /

+0.425 (+0.77%)

04/01/21 SVB Leerink
Phreesia price target lowered to $75 from $85 at SVB Leerink
04/01/21 Baird
Phreesia initiated with an Outperform at Baird
03/31/21 Piper Sandler
Phreesia price target raised to $58 from $56 at Piper Sandler
03/31/21 KeyBanc
Phreesia price target lowered to $70 from $80 at KeyBanc
PHR Phreesia
$55.56 /

+0.425 (+0.77%)

  • 21
    Oct
PHR Phreesia
$55.56 /

+0.425 (+0.77%)

PHR Phreesia
$55.56 /

+0.425 (+0.77%)

Conference/Events
Phreesia participates in a conference call with Stephens » 04:55
04/06/21
04/06
04:55
04/06/21
04:55
PHR

Phreesia

$55.16 /

+0.04 (+0.07%)

Conference call with CEO…

Conference call with CEO Indig and CFO Altier to be held on April 6 at 2 pm hosted by Stephens.

ShowHide Related Items >><<
PHR Phreesia
$55.16 /

+0.04 (+0.07%)

PHR Phreesia
$55.16 /

+0.04 (+0.07%)

04/01/21 SVB Leerink
Phreesia price target lowered to $75 from $85 at SVB Leerink
04/01/21 Baird
Phreesia initiated with an Outperform at Baird
03/31/21 Piper Sandler
Phreesia price target raised to $58 from $56 at Piper Sandler
03/31/21 KeyBanc
Phreesia price target lowered to $70 from $80 at KeyBanc
PHR Phreesia
$55.16 /

+0.04 (+0.07%)

  • 21
    Oct
PHR Phreesia
$55.16 /

+0.04 (+0.07%)

PHR Phreesia
$55.16 /

+0.04 (+0.07%)

Over a week ago
Recommendations
Phreesia price target lowered to $75 from $85 at SVB Leerink » 07:57
04/01/21
04/01
07:57
04/01/21
07:57
PHR

Phreesia

$52.14 /

+0.045 (+0.09%)

SVB Leerink analyst…

SVB Leerink analyst Stephanie Davis Demko lowered the firm's price target on Phreesia to $75 from $85 and keeps an Outperform rating on the shares following quarterly results. The analyst notes that PHR shares were flat post call as solid top line performance was offset by muted management tone.

ShowHide Related Items >><<
PHR Phreesia
$52.14 /

+0.045 (+0.09%)

PHR Phreesia
$52.14 /

+0.045 (+0.09%)

04/01/21 Baird
Phreesia initiated with an Outperform at Baird
03/31/21 Piper Sandler
Phreesia price target raised to $58 from $56 at Piper Sandler
03/31/21 KeyBanc
Phreesia price target lowered to $70 from $80 at KeyBanc
01/14/21 Needham
Phreesia price target raised to $70 from $60 at Needham
PHR Phreesia
$52.14 /

+0.045 (+0.09%)

  • 21
    Oct
PHR Phreesia
$52.14 /

+0.045 (+0.09%)

PHR Phreesia
$52.14 /

+0.045 (+0.09%)

Initiation
Phreesia initiated with an Outperform at Baird » 06:05
04/01/21
04/01
06:05
04/01/21
06:05
PHR

Phreesia

$52.14 /

+0.045 (+0.09%)

Baird analyst Joe Vruwink…

Baird analyst Joe Vruwink initiated coverage of Phreesia with an Outperform rating and $60 price target.

ShowHide Related Items >><<
PHR Phreesia
$52.14 /

+0.045 (+0.09%)

PHR Phreesia
$52.14 /

+0.045 (+0.09%)

03/31/21 Piper Sandler
Phreesia price target raised to $58 from $56 at Piper Sandler
03/31/21 KeyBanc
Phreesia price target lowered to $70 from $80 at KeyBanc
01/14/21 Needham
Phreesia price target raised to $70 from $60 at Needham
01/08/21 Baird
Vocera downgraded to Neutral on valuation at Baird
PHR Phreesia
$52.14 /

+0.045 (+0.09%)

  • 21
    Oct
PHR Phreesia
$52.14 /

+0.045 (+0.09%)

PHR Phreesia
$52.14 /

+0.045 (+0.09%)

Recommendations
Phreesia price target raised to $58 from $56 at Piper Sandler » 13:52
03/31/21
03/31
13:52
03/31/21
13:52
PHR

Phreesia

$51.84 /

-0.25 (-0.48%)

Piper Sandler analyst…

Piper Sandler analyst Sean Wieland raised the firm's price target on Phreesia to $58 from $56 and reiterates an Overweight rating on the shares following the Q4 sales beat. The analyst sees an upward bias to fiscal 2022 guidance that already implies accelerating revenue growth. As such, he would remain a buyer of the stock.

ShowHide Related Items >><<
PHR Phreesia
$51.84 /

-0.25 (-0.48%)

PHR Phreesia
$51.84 /

-0.25 (-0.48%)

03/31/21 KeyBanc
Phreesia price target lowered to $70 from $80 at KeyBanc
01/14/21 Needham
Phreesia price target raised to $70 from $60 at Needham
01/08/21 Baird
Vocera downgraded to Neutral on valuation at Baird
01/04/21 Stephens
Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
PHR Phreesia
$51.84 /

-0.25 (-0.48%)

  • 21
    Oct
PHR Phreesia
$51.84 /

-0.25 (-0.48%)

PHR Phreesia
$51.84 /

-0.25 (-0.48%)

Recommendations
Phreesia price target lowered to $70 from $80 at KeyBanc » 08:28
03/31/21
03/31
08:28
03/31/21
08:28
PHR

Phreesia

$52.25 /

+1.46 (+2.87%)

KeyBanc analyst Donald…

KeyBanc analyst Donald Hooker lowered the firm's price target on Phreesia to $70 from $80 due to the negative impact of rising interest rates on SaaS trading valuations. The analyst notes the company reported strong Q4 revenue growth and continues to see material upside potential in the shares from here. He keeps an Overweight rating on the shares.

ShowHide Related Items >><<
PHR Phreesia
$52.25 /

+1.46 (+2.87%)

PHR Phreesia
$52.25 /

+1.46 (+2.87%)

01/14/21 Needham
Phreesia price target raised to $70 from $60 at Needham
01/08/21 Baird
Vocera downgraded to Neutral on valuation at Baird
01/04/21 Stephens
Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
12/14/20 Citi
Phreesia price target raised to $59 from $33 at Citi
PHR Phreesia
$52.25 /

+1.46 (+2.87%)

  • 21
    Oct
PHR Phreesia
$52.25 /

+1.46 (+2.87%)

PHR Phreesia
$52.25 /

+1.46 (+2.87%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.